Synthesis and Antiarrhythmic Activity of 1-Benzyl-3,3-Dialkyl-3,4-Dihydroisoquinoline Chlorides
- Authors: Mikhailovskii A.G.1, Gashkova O.V.1, Rudakova I.P.1, Peretyagin D.A.1
- 
							Affiliations: 
							- Perm State Pharmaceutical Academy
 
- Issue: Vol 51, No 7 (2017)
- Pages: 546-549
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244700
- DOI: https://doi.org/10.1007/s11094-017-1651-y
- ID: 244700
Cite item
Abstract
Cyclocondensation of dialkylbenzylcarbinols with benzylcyanides was used to synthesize 1-benzyl-3,3-dialkyl-3,4-dihydroisoquinolines. The hydrochlorides of the compounds synthesized here were tested for antiarrhythmic activity in a calcium chloride model. The maximum antiarrhythmic index (AI) was found with isoquinolines with cycloalkanone fragments such as cyclopentanone and cyclohexanone in position 3, which had AI values of 15.5 and 16.3, three times the corresponding value for lidocaine.
About the authors
A. G. Mikhailovskii
Perm State Pharmaceutical Academy
							Author for correspondence.
							Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm						
O. V. Gashkova
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm						
I. P. Rudakova
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm						
D. A. Peretyagin
Perm State Pharmaceutical Academy
														Email: ajm@perm.ru
				                					                																			                												                	Russian Federation, 							Perm						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					